Paper46958
Gallbladder disease in hyperlipoproteinaemia.
Einarsson K and 2 others. Lancet, 1975. Cited by 76 papers, by iCite.
Cite this record
ConductScience Library. Gallbladder disease in hyperlipoproteinaemia. Papers, record 46958. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/46958
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Gallbladder Diseases | Major topic |
| Hyperlipidemias | Major topic |
| Lipoproteins | Major topic |
| Age Factors | |
| Body Weight | |
| Cholecystitis | |
| Cholelithiasis | |
| Cholesterol | |
| Female | |
| Glucose Tolerance Test | |
| Humans | |
| Male | |
| Middle Aged | |
| Sex Ratio | |
| Triglycerides |
Source PubMed
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 76 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39015929 | Association of education with cholelithiasis and mediating effects of cardiometabolic factors: A Mendelian randomization study. | World J Clin Cases | 2024 | https://conductscience.org/library/papers/39015929 | PubMed |
| 37909007 | Significant High Lipid Profile in a Woman With Obstructive Jaundice. | JCEM Case Rep | 2023 | https://conductscience.org/library/papers/37909007 | PubMed |
| 36568240 | Benign gallbladder disease is a risk factor for colorectal cancer, but cholecystectomy is not: A propensity score matching analysis. | Front Oncol | 2022 | https://conductscience.org/library/papers/36568240 | PubMed |
| 31065353 | Comparative analysis of serum lipid profiles in patients with and without gallstones: A prospective cross-sectional study. | Ann Med Surg (Lond) | 2019 | https://conductscience.org/library/papers/31065353 | PubMed |
| 23419155 | Prevention of cholesterol gallstones by inhibiting hepatic biosynthesis and intestinal absorption of cholesterol. | Eur J Clin Invest | 2013 | https://conductscience.org/library/papers/23419155 | PubMed |
| 12477770 | Gall bladder dysmotility: a risk factor for gall stone formation in hypertriglyceridaemia and reversal on triglyceride lowering therapy by bezafibrate and fish oil. | Gut | 2003 | https://conductscience.org/library/papers/12477770 | PubMed |
| 7560101 | Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene. | J Clin Invest | 1995 | https://conductscience.org/library/papers/7560101 | PubMed |
| 7389534 | Gallbladder disease and hyperlipoproteinemia. | Dig Dis Sci | 1980 | https://conductscience.org/library/papers/7389534 | PubMed |
| 7333446 | Serum lipids and lipoproteins in patients with gallstone (relationship between serum lipids and types of stones in roentgenograms and sectional views). | Gastroenterol Jpn | 1981 | https://conductscience.org/library/papers/7333446 | PubMed |
| 7009140 | Chenodeoxycholic acid: a review of its pharmacological properties and therapeutic use. | Drugs | 1981 | https://conductscience.org/library/papers/7009140 | PubMed |
| 6876687 | [Relation between serum lipoprotein metabolism and biliary lipid metabolism]. | Klin Wochenschr | 1983 | https://conductscience.org/library/papers/6876687 | PubMed |
| 6432171 | Plasma lipids and insulin in gall stone disease: a case-control study. | Br Med J (Clin Res Ed) | 1984 | https://conductscience.org/library/papers/6432171 | PubMed |
| 4021742 | Evidence for distinct precursor pools for biliary cholesterol and primary bile acids in cebus and cynomolgus monkeys. | Lipids | 1985 | https://conductscience.org/library/papers/4021742 | PubMed |
| 3699565 | Gall stone disease without gall stones--bile acid and bile lipid metabolism after complete gall stone dissolution. | Gut | 1986 | https://conductscience.org/library/papers/3699565 | PubMed |
| 873335 | Cholelithiasis in subjects with hypercalcaemia and primary hyperparathyroidism detected in a health screening. | Gut | 1977 | https://conductscience.org/library/papers/873335 | PubMed |
| 803123 | Familial hyperlipoproteinemia and gallstones. | Can Med Assoc J | 1975 | https://conductscience.org/library/papers/803123 | PubMed |
| 685927 | Clofibrate therapy and gallstone induction. | Am J Dig Dis | 1978 | https://conductscience.org/library/papers/685927 | PubMed |
| 656777 | Resistance to chenodeoxycholic acid (CDCA) treatment in obese patients with gall stones. | Br Med J | 1978 | https://conductscience.org/library/papers/656777 | PubMed |
| 468079 | Lipid composition of bile in diabetics and obesity-matched controls. | Gut | 1979 | https://conductscience.org/library/papers/468079 | PubMed |
| 222561 | Prevalence of gallbladder disease in hyperlipoproteinemia. | Dig Dis Sci | 1979 | https://conductscience.org/library/papers/222561 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/46958
GET https://conductscience.org/api/papers/v1/46958/authors